Geneos Wealth Management Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 98 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,702
+3.2%
110
+4.8%
0.00%
Q2 2023$1,650
-4.6%
1050.0%0.00%
Q1 2023$1,730
-85.6%
105
-88.4%
0.00%
-100.0%
Q2 2022$12,000
-25.0%
905
-19.1%
0.00%0.0%
Q1 2022$16,000
+6.7%
1,1190.0%0.00%0.0%
Q4 2021$15,000
-54.5%
1,119
-44.4%
0.00%0.0%
Q3 2021$33,0000.0%2,0140.0%0.00%0.0%
Q2 2021$33,000
-5.7%
2,014
-4.8%
0.00%0.0%
Q1 2021$35,000
-7.9%
2,116
+1.7%
0.00%
-50.0%
Q4 2020$38,000
-54.2%
2,081
-53.9%
0.00%
-50.0%
Q3 2020$83,000
+1.2%
4,5140.0%0.00%
-20.0%
Q2 2020$82,000
+18.8%
4,5140.0%0.01%0.0%
Q1 2020$69,000
+176.0%
4,514
+255.7%
0.01%
+400.0%
Q4 2019$25,000
+13.6%
1,2690.0%0.00%0.0%
Q3 2019$22,0000.0%1,2690.0%0.00%0.0%
Q2 2019$22,000
-18.5%
1,269
-7.2%
0.00%
-50.0%
Q1 2019$27,000
+350.0%
1,367
+275.5%
0.00%
Q4 2018$6,000
-14.3%
3640.0%0.00%
Q3 2018$7,0000.0%3640.0%0.00%
-100.0%
Q2 2018$7,000
-12.5%
3640.0%0.00%0.0%
Q1 2018$8,000
-20.0%
3640.0%0.00%0.0%
Q4 2017$10,0000.0%3640.0%0.00%0.0%
Q3 2017$10,000
+11.1%
3640.0%0.00%0.0%
Q2 2017$9,000
+12.5%
3640.0%0.00%0.0%
Q1 2017$8,0003640.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders